All results
40 results for breast cancer
-
DoD Mastectomy
Breast cancer is the most common type of cancer in women. Removal of the breast, called "mastectomy", is performed either when there is cancer-or an increased…
- Ages
- 18 Years - N/A
- Sexes
- All
-
PVT-2201-301
This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of treatment with brepocitinib (TYK2/JAK1 inhibitor) in adults with…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
Camostat Mesilate
The purpose of this study is to determine the safety and efficacy of NI-03. The primary objective of the Single-Dose Phase is to assess the pharmacokinetics…
- Ages
- 18 Years - 85 Years
- Sexes
- All
-
Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE)
The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will…
- Ages
- 18 Years - N/A
- Sexes
- All
-
PNOC020:RNA-Lipid Particle Vaccines for Newly Diagnosed Ped HGG and Adult GBM
The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in…
- Ages
- 21 Years - N/A
- Sexes
- All
-
ARGX-113-2007
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Compare Chemo Before and After Surgery vs After Surgery Alone for the TX of Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Study of XL092 in Comb. with Immuno-Oncology Agents in Subjects With Solid Tumors (STELLAR-002)
This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, PK, preliminary antitumor…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing the Combination of ZEN-3694 and Talazoparib in Ps w/ Advanced Solid Tumors; ComBET
This phase II trial tests whether ZEN003694 (ZEN-3694) in combination with talazoparib works to shrink tumors in patients with solid tumors that are unlikely…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering…
- Ages
- 12 Months - 21 Years
- Sexes
- All